MedAdvisor Price Target Raised 4.3% to A$0.49/Share by Bell Potter
MedAdvisor Price Target Raised 4.3% to A$0.49/Share by Bell Potter
MedAdvisor Solutions Forecasts Continued Growth for FY25 After Stellar Year
MedAdvisor Solutions (ASX: MDR) is forecasting further strong growth over the next 12 months after achieving robust recent performances in sales and revenue.
MedAdvisor to Deliver Maiden Profit in Fiscal 2024; Shares Jump 14%
MedAdvisor (ASX:MDR) is poised to deliver its maiden full-year earnings and net profit after tax, thanks to contributions from its intelligent patient management platform, according to a Wednesday filing with the Australian bourse.
MedAdvisor Ltd: MDR Record FY24 Performance with Positive EBITDA and NPAT
MedAdvisor Limited's (ASX:MDR) Path To Profitability
MedAdvisor Price Target Raised 6.8% to A$0.47/Share by Bell Potter
MedAdvisor Price Target Raised 6.8% to A$0.47/Share by Bell Potter
MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter
MedAdvisor (ASX:MDR) has posted a 42% operating revenue increase on the prior year to AU$24.2 million for the quarter ended March 31, while year-to-date revenue rose 23% to AU$99.8 million on the prio
PVM Adjusts Stake in MedAdvisor Ltd
Shareholders in MedAdvisor (ASX:MDR) Are in the Red If They Invested Five Years Ago
MedAdvisor Price Target Raised 4.8% to A$0.44/Share by Bell Potter
MedAdvisor Price Target Raised 4.8% to A$0.44/Share by Bell Potter
MedAdvisor Reports Higher Attributable Profit, Revenue in Fiscal H1
MedAdvisor (ASX:MDR) reported Thursday that its profit attributable to shareholders after tax in the six months ended Dec. 31, 2023, increased to AU$6.9 million compared with the prior-year period's A
Institutions Profited After MedAdvisor Limited's (ASX:MDR) Market Cap Rose AU$41m Last Week but Private Companies Profited the Most
MedAdvisor Secures Scope of Practice Pilot Contract; Shares Decline 3%
MedAdvisor (ASX:MDR) secured a contract to develop and deliver enhancements to its PlusOne software platform to support the 2024-2025 North Queensland community pharmacy scope of practice pilot, the m
MedAdvisor Initiated at Buy by Bell Potter
MedAdvisor Initiated at Buy by Bell Potter
MedAdvisor Started at Buy by Canaccord Genuity >MDR.AU
MedAdvisor Started at Buy by Canaccord Genuity >MDR.AU
The Past Three Years for MedAdvisor (ASX:MDR) Investors Has Not Been Profitable
No Data